ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Who’s Going to ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

1,101 organizations and 2,720 people on the program at ACR Convergence 2026, the American College of Rheumatology (ACR) annual meeting, a ~15,000-person, mostly clinical meeting of rheumatologists, allied health professionals and researchers. As of Nov 2, 2026.

Format
Topic
Top represented
Showing 1–1 of 1,101 organizations
OrganizationACR Convergence 2026 Attendance
Hospitals and health systems
A hospital specializing in orthopedic surgery and rheumatic diseases.
Session
Sat Nov 7
7:45am–12:00pm
Review Course
Hall B, WB3 and WB4
Education and careers · with Hackensack University Medical Center
  1. 7:50amCheck Your Knowledge Management of Rheumatic Diseases Induced by Cancer ImmunotherapyJohns Hopkins University
  2. 8:25amGenetics in Rheumatology: What Every Clinician Needs to KnowGenentech
  3. 9:00amReproductive Health for the RheumatologistUniversity of Pittsburgh
  4. 10:10amGut Instinct: What's New in Inflammatory Bowel Disease-Associated ArthritisUniversity of Colorado Anschutz Medical Campus
  5. 10:45amGlucocorticoid-Induced Osteoporosis in Adults and ChildrenVA Puget Sound Health Care System
  6. 11:20amUpdates in Polymyalgia RheumaticaMedical College of Wisconsin
Talk
Sat Nov 7
1:30pm–2:00pm
Part of Radiology Bootcamp
Hyperparathyroidism
W415BC
Imaging and ultrasound
Talk
Sat Nov 7
3:00pm–3:45pm
Building & Retaining the Rheumatology Workforce: APPs
W415A
Practice management · with Northwell, Advocate Health
Session
Sun Nov 8
7:30am–8:30am
Year in Review
Hall B, WB3 and WB4
Education and careers · with University of California, Los Angeles, University of Washington
  1. 7:30amYear in Review: Basic ScienceStanford University
  2. 8:00amYear in Review: Clinical ScienceBerkshire Medical Center
Talk
Sun Nov 8
9:00am–9:30am
Part of Patient-Facing Decision Tree: Best Practice Suggestions for Vasculitis
Improved Patient and Provider Partnering Reduces Both Provider and Patient Burdens
W311GH
Vasculitis
Session
Sun Nov 8
10:00am–11:30am
CAR-T Cell Therapy in 2026
W415D
Treatment safety · with University of North Carolina
  1. 10:00amCell Therapy in SLE and Other Rheumatic Autoimmune Diseases: Where We Are in 2026Hospital for Special Surgery
  2. 10:30amCell Therapy in SclerodermaUniversity of Michigan
  3. 11:00amCellular Therapies in Autoimmunity: What It Takes to Get It DoneUniversity of Pittsburgh
Talk
Sun Nov 8
10:00am–10:30am
Part of CAR-T Cell Therapy in 2026
Cell Therapy in SLE and Other Rheumatic Autoimmune Diseases: Where We Are in 2026
W415D
Treatment safety
Session
Sun Nov 8
10:00am–11:30am
Precision Over Prednisone: Mechanism-Based Therapy for Dermatomyositis in the Modern Era
W304A-H
Myositis · with University of Calgary
  1. 10:00amNovel Agents Targeting Interferon Signaling in DermatomyositisUniversity of Chicago
  2. 10:30amImmunoglobulin Therapy in MyositisUniversity of Pittsburgh
  3. 11:00amNeonatal Fc Receptor Inhibitors in MyositisStanford University
Poster
Sun Nov 8
10:30am–12:30pm
Poster
Sun Nov 8
10:30am–12:30pm
Session
Sun Nov 8
10:30am–11:30am
Evolving Treatment Landscape of Autoimmune Interstitial Lung Disease: Where Do New Medications Fit in the Existing Treatment Paradigm
W415A
Systemic sclerosis · with University of California, Los Angeles
  1. 10:30amWhere Do New Treatments Fit in the Current Autoimmune ILD Treatment Paradigm? Perspective of a PulmonologistCedars-Sinai Medical Center
  2. 11:00amTreating the Whole Patient: How ILD-Targeted Therapies Affect Extra-Pulmonary Features of Autoimmune DiseasesMassachusetts General Hospital
Session
Sun Nov 8
10:30am–11:30am
Fibroblasts as Orchestrators in Psoriatic Arthritis and Immunity: Running the Circuit from Skin-to-Joint
W110B
Spondyloarthritis and PsA
  1. 10:30amFibroblastic Reticular Cells Direct the Initiation of T Cell Responses via CD44Monash University
  2. 11:00amSkin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to JointsUniversity Hospital Erlangen
Session
Sun Nov 8
10:30am–11:30am
GLP-1 Receptor Agonists: Perspectives on Use in Autoimmune Inflammatory Rheumatic Diseases
W415BC
Patient care · with University of Toronto, New York University
  1. 10:30amGLP-1 Receptor Agonists: Mechanisms and Medication LandscapeNew York University
  2. 11:00amGLP-1 Receptor Agonists: Use in Autoimmune Inflammatory Rheumatic DiseasesUniversity of California, Los Angeles
Session
Sun Nov 8
10:30am–11:30am
Quality Payment Program Reporting for 2026 - The New RISE Registry QPP
W315
Patient care · with University of Wisconsin
  1. 10:30amAcademic PerspectiveUniversity of Alabama at Birmingham
  2. 11:00amNew RISE Registry: Community Organization PerspectiveAbeles Rheumatology
Session
Sun Nov 8
1:00pm–2:30pm
Talk
Sun Nov 8
1:35pm–1:55pm
Part of Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 1
Potential Side Effects of Cellular Therapies: ICAN Be Aware of These Potentially CRiouS Issues
Hall B, WB3 and WB4
Treatment safety
Industry
Sun Nov 8
2:30pm–3:15pm
Make Rheum for Lungs: Treating Progressive Pulmonary Fibrosis in Your Patients
Innovation Theater A
Rare and other diseases · Offered by Boehringer Ingelheim
Session
Sun Nov 8
3:00pm–4:00pm
Aging Networking Lounge
W307A
Patient care
Session
Sun Nov 8
4:00pm–5:00pm
Friend or Foe: NK cells in Health, Disease, and Therapeutics
W204
Immunology · with Beth Israel Deaconess Medical Center, Children's Hospital of Philadelphia
  1. 4:00pmTissue-Resident NK Cells in Protecting TissuesMonash University
  2. 4:30pmRoles and Functions of NK Cells in Disease and for TherapeuticsUniversity of Colorado Anschutz Medical Campus
Industry
Sun Nov 8
5:30pm–7:30pm
Preventing Progression in Lupus: Are You Intervening Early Enough?
Hyatt Regency Orlando, Regency Ballroom Q
Lupus · Supported by GSK · with University of California, San Francisco
Poster
Mon Nov 9
10:30am–12:30pm
Talk
Mon Nov 9
11:00am–11:30am
Part of Cracking the Psoriatic Code: Cells, Circuits, and Cytokines in Psoriasis and Psoriatic Arthritis
From Cells to Clinic: How Distinct Cellular and Molecular Pathways Shape Distinct RA and PsA Pathotypes
W415BC
Spondyloarthritis and PsA
Talk
Mon Nov 9
11:00am–11:30am
Part of Interdisciplinary Care of the Patient with SLE - A Case Study
Strategies to Help Your Patient Overcome Barriers to Optimal Care in Lupus
W311EF
Lupus
Talk
Mon Nov 9
1:00pm–1:30pm
Part of When the Message Changes: Nucleic Acid Modifications in Rheumatic Disease
The Role of Nucleic Acids in Autoimmunity in Fibrosis
W204
Immunology
Talk
Mon Nov 9
1:40pm–2:15pm
Part of Cellular Immunotherapy: Are We on the Cusp of a Therapeutic Revolution in Rheumatology? Session 2
Update in Outcomes of Adult Patients Treated with Cellular Therapies
Hall B, WB3 and WB4
Treatment safety
Talk
Mon Nov 9
2:30pm–3:00pm
Part of Microvascular Antiphospholipid Syndrome (APS): Present Challenges and Future Opportunities
Defining Microvascular APS: Clinical Features, Classification, and Management
W415A
Lupus
Session
Mon Nov 9
2:30pm–3:30pm
Microvascular Antiphospholipid Syndrome (APS): Present Challenges and Future Opportunities
W415A
Lupus · with University of California, Los Angeles
  1. 2:30pmDefining Microvascular APS: Clinical Features, Classification, and ManagementHospital for Special Surgery
  2. 3:00pmEmerging Disease Mechanisms and Therapeutic Opportunities in Microvascular APSUniversity of Michigan
Industry
Mon Nov 9
5:30pm–7:30pm
Every Conversation Counts: Supporting Disease Control Across the SLE Reproductive Journey
Hyatt Regency Orlando, Windermere Ballroom Y
Lupus · Pregnancy · Supported by UCB, Biogen · with Duke University
Session
Tue Nov 10
10:00am–11:30am
Not Your Parents' Sarcoidosis: Beyond Granulomas and Steroids
W304A-H
Rare and other diseases · with Stanford University
  1. 10:00am21st Century Treatment Paradigms and Medications for Sarcoidosis (Steroids Are So 1950s)Cedars-Sinai Medical Center
  2. 10:30amSarcoid Small Fiber Neuropathy: The Biggest Pain Is Not Even GranulomatousVirginia Commonwealth University
  3. 11:00amVitamin D and Calcium in Sarcoidosis: The Goldilocks ParadoxHospital for Special Surgery
Poster
Tue Nov 10
10:30am–12:30pm
Improving Access to Pediatric Rheumatology Medical Education
WB1&2 · Poster 2478
Education and careers
Poster
Tue Nov 10
10:30am–12:30pm
Poster
Tue Nov 10
10:30am–12:30pm
Poster
Tue Nov 10
10:30am–12:30pm
Talk
Tue Nov 10
11:00am–11:30am
Part of Not Your Parents' Sarcoidosis: Beyond Granulomas and Steroids
Vitamin D and Calcium in Sarcoidosis: The Goldilocks Paradox
W304A-H
Rare and other diseases
Session
Tue Nov 10
1:00pm–2:30pm
Daltroy Lecture: From Labs to Living Rooms: Communicating Research Through Patient-Centered Community Engagement
W308
Patient care · with Emory University
  1. 1:00pmFrom Labs to Living Rooms: Communicating Research Through Patient-Centered Community Engagement 1University of Rochester
  2. 1:30pmFrom Labs to Living Rooms: Communicating Research Through Patient-Centered Community Engagement 3
  3. 2:00pmFrom Labs to Living Rooms: Communicating Research Through Patient-Centered Community Engagement 2Emory University
Talk
Tue Nov 10
1:00pm–1:20pm
Part of Cellular Immunotherapy: Are we on the Cusp of a Therapeutic Revolution in Rheumatology? Session 3
Patients and Cellular Therapies: Organizing and Running Clinical Trials, and Where to Find them
Chapin Theater
Treatment safety
Session
Tue Nov 10
2:30pm–3:30pm
More on the Lupus Guideline 2026
W415A
Lupus · with The Hospital for Sick Children
  1. 2:30pmNew Approved Treatments for Lupus, Where They May Fit in the GLHospital for Special Surgery
  2. 2:50pmGuidelines for the Treatment of NP-SLEUniversity of California, San Francisco
  3. 3:10pmGuideline for More Rare ManifestationsHospital for Special Surgery
Talk
Tue Nov 10
2:30pm–2:50pm
Part of More on the Lupus Guideline 2026
New Approved Treatments for Lupus, Where They May Fit in the GL
W415A
Lupus
Talk
Tue Nov 10
3:10pm–3:30pm
Part of More on the Lupus Guideline 2026
Guideline for More Rare Manifestations
W415A
Lupus
Industry
Tue Nov 10
5:30pm–7:30pm
A Key Source of the Signal: Rethinking Lupus Skin and Joint Disease
Hyatt Regency Orlando, Windermere Ballroom W
Lupus · Supported by Biogen · with Brigham and Women's Hospital
Session
Wed Nov 11
8:00am–9:00am
Patient Perspectives
W414
Patient care
  1. 8:15amLearning Through Lived Experience: Supporting Students with Rheumatic DiseasesToronto Metropolitan University
  2. 8:30amNo One Explained My Gout, and It Nearly Broke Me, Now I Explain It So It Won't Break ThemGout Support Group of America
  3. 8:45amFrom Lockdown to Global Reach: How Living With EGPA Led Me to Build a Psychosocial Support Program for People with Vasculitis
Session
Wed Nov 11
8:30am–9:30am
Myositis Mimics - Mitochondrial and Metabolic Myopathies, and Clinical Pearls
W109
Myositis · with Johns Hopkins University, McGill University

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from organizations at ACR Convergence 2026

Tell us what you sell and we’ll find the people at these organizations most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

When and where was ACR Convergence 2026?

ACR Convergence 2026 ran November 6–11, 2026, at the Orange County Convention Center in Orlando, FL.

What is ACR Convergence 2026?

ACR Convergence 2026 is the annual meeting of the American College of Rheumatology, held November 6–11, 2026 at the Orange County Convention Center in Orlando, Florida. About 15,000 people attend: rheumatologists, rheumatology nurses, physician assistants and other health professionals, basic and translational immunologists, and the drug developers, diagnostics companies and patient organizations working on autoimmune and inflammatory disease. The program runs plenary and abstract sessions, thousands of posters, review and ultrasound courses, Meet the Professor sessions, industry-supported symposia and Innovation Theater talks, around an exhibit hall.

What is in this guide?

Every organization we can place at ACR Convergence 2026: the 168 exhibitors in the exhibit hall with their booth numbers, and the employers of the 2,720 speakers, moderators and poster presenters on the public program (3,850 program rows, including 2,562 posters, the industry-supported symposia and Innovation Theater talks) — 1,101 organizations in one list. People appear as job titles or counts, never by name.

Where does this list come from?

Two sources from the organizer: the meeting’s online program, with each presenter’s affiliation and the ACR’s own track for every session, and the exhibit hall floor plan with each exhibitor’s own profile. Each industry event’s supporting company is named in its own program description. Short descriptions are condensed from each exhibitor’s profile or its own website, or state what is well established about the organization.

How are organizations typed?

By what each organization is: universities and medical schools, hospitals and health systems, private rheumatology practices, drug developers (pharma and biotech), diagnostics and research tools companies, clinical research and other service providers, and government, societies, patient groups and publishers. The topic tags (lupus, rheumatoid arthritis, vasculitis, imaging and more) come from the ACR’s own track for each session an organization takes part in and, for exhibitors, from their own profile, at most three.

How current is it?

The exhibitors and booth numbers were pulled from the ACR’s public floor plan on November 2, 2026. The program is as of October 25, 2026, our last reading of it: the ACR’s session pages now need an ACR sign-in, so sessions added, moved or withdrawn since then do not show here. Exhibit hall hours are from that program. Both can still change before the meeting.

Why don’t session titles open the ACR’s program?

The ACR’s online program now sends visitors to an ACR sign-in page, so this guide no longer links to it. A poster or abstract talk opens its public abstract on ACR Meeting Abstracts (acrabstracts.org), and an abstract session its list of abstracts there. Other session titles are plain text: to read those sessions’ pages you need to sign in to your ACR account.

Why are there no names?

This guide is about which organizations are in the room, not which people. It never publishes a person’s name.

Browse ACR Convergence 2026 by

Exhibit hall

Organizations with their own page

648 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction